These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29031696)

  • 41. Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation.
    Rothstein E; Kohl KS; Ball L; Halperin SA; Halsey N; Hammer SJ; Heath PT; Hennig R; Kleppinger C; Labadie J; Varricchio F; Vermeer P; Walop W;
    Vaccine; 2004 Jan; 22(5-6):575-85. PubMed ID: 14741147
    [No Abstract]   [Full Text] [Related]  

  • 42. Hypotonic-Hyporesponsive Episode (HHE) as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation.
    Bonhoeffer J; Gold MS; Heijbel H; Vermeer P; Blumberg D; Braun M; de Souza-Brito G; Davis RL; Halperin S; Heininger U; Khuri-Bulos N; Menkes J; Nokleby H;
    Vaccine; 2004 Jan; 22(5-6):563-8. PubMed ID: 14741145
    [No Abstract]   [Full Text] [Related]  

  • 43. Pathways to preterm birth: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    Harrison MS; Eckert LO; Cutland C; Gravett M; Harper DM; McClure EM; Nunes AP; Lazo S; Moore TM; Watson W; Kochhar S; Goldenberg RL;
    Vaccine; 2016 Dec; 34(49):6093-6101. PubMed ID: 27491689
    [No Abstract]   [Full Text] [Related]  

  • 44. Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation.
    Bines JE; Kohl KS; Forster J; Zanardi LR; Davis RL; Hansen J; Murphy TM; Music S; Niu M; Varricchio F; Vermeer P; Wong EJ;
    Vaccine; 2004 Jan; 22(5-6):569-74. PubMed ID: 14741146
    [No Abstract]   [Full Text] [Related]  

  • 45. Persistent crying in infants and children as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation.
    Bonhoeffer J; Vermeer P; Halperin S; Kempe A; Music S; Shindman J; Walop W;
    Vaccine; 2004 Jan; 22(5-6):586-91. PubMed ID: 14741148
    [No Abstract]   [Full Text] [Related]  

  • 46. Detecting adverse drug reactions.
    Rosenbloom D; Wynne C
    CMAJ; 1999 Aug; 161(3):247-8. PubMed ID: 10463044
    [No Abstract]   [Full Text] [Related]  

  • 47. Non-reassuring fetal status: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Gravett C; Eckert LO; Gravett MG; Dudley DJ; Stringer EM; Mujobu TB; Lyabis O; Kochhar S; Swamy GK;
    Vaccine; 2016 Dec; 34(49):6084-6092. PubMed ID: 27461459
    [No Abstract]   [Full Text] [Related]  

  • 48. Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study.
    Gold MS; Gidudu J; Erlewyn-Lajeunesse M; Law B;
    Vaccine; 2010 Jun; 28(28):4487-98. PubMed ID: 20434547
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SOP 08: Reporting of adverse events.
    Onkologie; 2003 Oct; 26 Suppl 6():41-2. PubMed ID: 23570185
    [No Abstract]   [Full Text] [Related]  

  • 50. European Medicines Agency assesses safety reporting at Roche.
    Marshall H
    Lancet Oncol; 2012 Aug; 13(8):e331. PubMed ID: 23024993
    [No Abstract]   [Full Text] [Related]  

  • 51. SOP 04: Data collection forms (case report forms).
    Onkologie; 2003 Oct; 26 Suppl 6():15-22. PubMed ID: 23570180
    [No Abstract]   [Full Text] [Related]  

  • 52. Vienna Vaccine Safety Initiative.
    Rath B
    Hum Vaccin Immunother; 2018 May; 14(5):1038-1041. PubMed ID: 29206079
    [No Abstract]   [Full Text] [Related]  

  • 53. Reporting of vaccine safety data in publications: systematic review.
    Bonhoeffer J; Zumbrunn B; Heininger U
    Pharmacoepidemiol Drug Saf; 2005 Feb; 14(2):101-6. PubMed ID: 15386705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of gender on reporting of MMR adverse events in Saudi Arabia.
    Khalil MK; Al-Mazrou YY; Al-Ghamdi YS; Tumsah S; Al-Jeffri M; Meshkhas A
    East Mediterr Health J; 2003; 9(1-2):152-8. PubMed ID: 15562745
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Web-based intensive monitoring of adverse events following influenza vaccination in general practice.
    van Balveren-Slingerland L; Kant A; Härmark L
    Vaccine; 2015 May; 33(19):2283-2288. PubMed ID: 25797367
    [No Abstract]   [Full Text] [Related]  

  • 56. Deaths following pentavalent vaccine and the revised AEFI classification.
    Puliyel J; Phadke A
    Indian J Med Ethics; 2017; 2(4):300-301. PubMed ID: 28803220
    [No Abstract]   [Full Text] [Related]  

  • 57. COVID-19 Vaccination in Patients With Inflammatory Bowel Disease and History of Reaction to Injectable Therapies.
    Squire JD; Gonzalez-Estrada A; Caldera F; Farraye FA
    Inflamm Bowel Dis; 2021 Jul; 27(8):1358-1360. PubMed ID: 33999204
    [No Abstract]   [Full Text] [Related]  

  • 58. Guidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy.
    Jones CE; Munoz FM; Kochhar S; Vergnano S; Cutland CL; Steinhoff M; Black S; Heininger U; Bonhoeffer J; Heath PT
    Vaccine; 2016 Dec; 34(49):6007-6014. PubMed ID: 27793485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
    LaRussa PS; Edwards KM; Dekker CL; Klein NP; Halsey NA; Marchant C; Baxter R; Engler RJ; Kissner J; Slade BA
    Pediatrics; 2011 May; 127 Suppl 1():S65-73. PubMed ID: 21502239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Monitoring and assessing vaccine safety: a European perspective.
    Lopalco PL; Johansen K; Ciancio B; De Carvalho Gomes H; Kramarz P; Giesecke J
    Expert Rev Vaccines; 2010 Apr; 9(4):371-80. PubMed ID: 20370548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.